Radiorecurrent prostate cancer: An emerging and largely mismanaged epidemic

European Urology

Volumn 60, Issue 3, 2011, Pages 411-412

  Jones, J Stephen ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ANDROGEN DEPRIVATION THERAPY; ANTIANDROGEN THERAPY; BRACHYTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CRYOABLATION; DISEASE FREE SURVIVAL; EDITORIAL; EPIDEMIC; EXTERNAL BEAM RADIOTHERAPY; HIGH INTENSITY FOCUSED ULTRASOUND; METASTASIS; MORBIDITY; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RADIORECURRENT PROSTATE CANCER; SALVAGE THERAPY; SCIENTIFIC LITERATURE; TREATMENT FAILURE; TUMOR BIOPSY;

BRACHYTHERAPY; CRYOTHERAPY; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS; SALVAGE THERAPY;

EID: 79961017477     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.01.007     Document Type: Editorial

References (7)

1. Touma NJ, Izawa JI, Chin JL. Current status of local salvage therapies following radiation failure for prostate cancer. J Urol 2005;173:373-9.
2. Grossfeld GD, Li YP, Lubeck DP, et al. Predictors of secondary cancer treatment in patients receiving local therapy or prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol 2002;168:530-5. (Pubitemid 34793288)
3. Cooperberg MR, Vickers AJ, Broering JM, Carroll PR. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer 2010;116:5226-34.
4. Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010;28:1117-23.
5. Williams AK, Martínez CH, Lu C, Ng CK, Pautler SE, Chin JL. Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer. Eur Urol 2011;60:405-10.
6. Izawa JI, Madsen LT, Scott SM, et al. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. J Clin Oncol 2002;20:2664-71. (Pubitemid 34575639)
7. Jones JS. Ultrasound probe positioning to minimize the risk of recto-urethral fistula during cryosurgical ablation of prostate cancer. BJU 2007;100:58-62. (Pubitemid 46878553)